Date: 2015-01-12
Type of information: Collaboration agreement
Compound: antibodies for use in Dako-branded companion diagnostics products
Company: Dako (Denmark) Cell Signaling Technology (USA - MA)
Therapeutic area: Diagnostic
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On January 12, 2015, Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology (CST), a worldwide provider of antibodies, announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products.
Financial terms: The financial details of the agreement were not disclosed.
Latest news:
